Skip to main content
OpenTrials
Completed

NCT Number: NCT07004062

Application Value of Targeted Nursing Based on Risk Assessment Strategies in the Treatment of Patients With Gynecological Endocrine Disorders

Risk-based targeted nursing significantly enhances clinical outcomes, quality of life, and mental health in patients with gynecological endocrine disorders, supporting its broader clinical application.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Gynecological Endocrine Disorders Psychological Support Quality of Life Risk Assessment Targeted Nursing Care

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Obstetrics and Gynecology Hospital of Fudan University

Shanghai, Shanghai Municipality, 200443, China

About this study

To evaluate the clinical value of targeted nursing care based on risk assessment in patients with gynecological endocrine disorders.

A prospective controlled study was conducted to analyze the clinical data of 84 patients with endocrine disorders and 89 healthy women, focusing on identifying risk factors associated with endocrine disorders and designing corresponding personalized nursing interventions. A total of 154 patients with gynecological endocrine disorders, treated between December 2023 and June 2024, were randomly assigned into a control group (n = 77) and an observation group (n = 77) using a random number table method. The control group received routine nursing care, while the observation group received targeted nursing interventions based on risk assessment strategies in addition to routine care. Nursing outcomes, patient satisfaction, quality of life scores, and psychological status-including Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) scores-were compared between the two groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinical diagnosis of gynecological endocrine disorder

Aged 18-45 years

Complete clinical data available

Willing and able to provide informed consent

Exclusion criteria

Severe systemic or psychiatric illness

Recent major surgery or hormonal/fertility treatment (within 3 months)

Known hypersensitivity to study medications

Currently pregnant or breastfeeding

Participation in another clinical trial within 6 months

Treatment and study plan

Structured Risk Assessment-Based Targeted Nursing Intervention

Other

Comprehensive Risk Assessment: Evaluation of lifestyle factors (diet, exercise, sleep), psychosocial stressors, medical history, and endocrine-specific biomarkers

Personalized Care Plan: Tailored interventions addressing identified risk factors

Psychological Component: Cognitive-behavioral techniques and stress management

Lifestyle Modification: Guided nutrition (low-glycemic, high-fiber diet) and physical activity plans

Reproductive Health Support: Menstrual cycle monitoring and fertility-related counseling

Primary outcomes

  1. Clinical Efficacy of Targeted Nursing in Gynecological Endocrine Disorders

    Time frame: Baseline to 6 months post-intervention.

    Proportion of patients achieving significant improvement in endocrine symptoms (e.g., menstrual regularity, hormonal balance) post-intervention, assessed via physician evaluation and laboratory markers (e.g., LH/FSH ratio, testosterone levels).

Secondary outcomes

  1. Patient Satisfaction with Nursing Care

    Time frame: End of intervention (Week 12).

    Satisfaction rates measured via a 5-point Likert scale survey (1 = "very dissatisfied" to 5 = "very satisfied"), including domains of communication, pain management, and emotional support.

Other outcomes

  1. Adherence to Lifestyle Interventions

    Time frame: Weekly during intervention (Weeks 1-12).

    Proportion of patients adhering to prescribed diet/exercise plans, recorded via self-reported logs and nurse audits.

Sponsors and collaborators

Lead sponsor

Obstetrics and Gynecology Hospital of Fudan University-Huangpu Campus

Other Gov

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jun 4, 2025
Registry last updated
Jun 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.